Dexcom G7 15 Day Continuous Glucose Monitoring System to Launch in Canada in November
Financial Post ·
The longest-lasting and most accurate1 continuous glucose monitoring (CGM) system authorized by Health Canada will offer people living with diabetes over the age of 18 up to 15.5 days of wear with fewer sensor changes.2 Dexcom G7 15 Day will be publicly reimbursed for many eligible Canadians living with diabetes beginning in November. Private health […]
BURNABY, British Columbia -- DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today that the Dexcom G7 15 Day Continuous Glucose Monitoring System (CGM) will be available in Canada beginning next month for adults 18 years and older living with diabetes. Offering up to 15.5 days of wear, 2 Dexcom G7 15 Day combines industry leading sensor duration with best-in-class accuracy, 1 giving Canadians living with diabetes more time between sensor changes and fewer interruptions to daily routines. Read More